Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Sumana Devata MD

Sumana Devata MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Medicine Hematology Oncology

View Curriculum Vitae

Publications (27)

  • Financial Toxicity in a Phase I/II Trial of LV20.19 CAR-T Cell for B-cell Malignancies: A Longitudinal, Qualitative Study. (Aughey E, Shah NN, Hillard CJ, Rentscher KE, Hamadani M, Longo W, Devata S, Knight JM, Cusatis R) Transplant Cell Ther 2026 May;32(5):621.e1-621.e11 PMID: 41485560 PMCID: PMC12952239 SCOPUS ID: 2-s2.0-105029718493 01/05/2026    
  • Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study. (Buradagunta CS, Garacci Z, D'Souza A, Dhakal B, Devata S, Janz S, Thrift AP, Hari P, Stolley M, Dong J) Blood Cancer J 2022 May 25;12(5):82 PMID: 35614050 PMCID: PMC9132975 SCOPUS ID: 2-s2.0-85130720530 05/26/2022       9 Citations
  • Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed. (Geer MJ, Foucar CE, Devata S, Benitez L, Perissinotti AJ, Marini BL, Bixby D) J Natl Compr Canc Netw 2021 Aug 17;19(11):1272-1275 PMID: 34404029 SCOPUS ID: 2-s2.0-85120085908 08/18/2021       7 Citations
  • Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis. (D'Angelo CR, Hanel W, Chen Y, Yu M, Yang D, Guo L, Karmali R, Burkart M, Ciccosanti C, David K, Risch Z, Murga-Zamalloa C, Devata S, Wilcox R, Savani M, Courville EL, Bachanova V, Rabinovich E, Peace D, Osman F, Epperla N, Kenkre VP) Hematol Oncol 2021 Oct;39(4):473-482 PMID: 34347909 PMCID: PMC10279769 SCOPUS ID: 2-s2.0-85111768372 08/05/2021       13 Citations
  • Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation. (Hu N, Wang F, Sun T, Xu Z, Zhang J, Bernard D, Xu S, Wang S, Kaminski M, Devata S, Phillips T, Malek SN) Clin Cancer Res 2021 Apr 15;27(8):2301-2313 PMID: 33419778 PMCID: PMC8046715 SCOPUS ID: 2-s2.0-85104295415 01/10/2021       21 Citations
  • Clinical application of next generation sequencing in lymphoma. (Scott AJ, Tokaz MC, Shango M, Devata S, Carty SA, Kaminski MS, Chinnaiyan AM, Phillips TJ, Wilcox RA) Leuk Lymphoma 2021 Apr;62(4):868-873 PMID: 33191827 SCOPUS ID: 2-s2.0-85096091400 11/17/2020       4 Citations
  • Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma. (Huen A, Haverkos BM, Zain J, Radhakrishnan R, Lechowicz MJ, Devata S, Korman NJ, Pinter-Brown L, Oki Y, Barde PJ, Nair A, Routhu KV, Viswanadha S, Vakkalanka S, Iyer SP) Cancers (Basel) 2020 Aug 15;12(8) PMID: 32824175 PMCID: PMC7463651 SCOPUS ID: 2-s2.0-85090253203 08/23/2020       64 Citations
  • A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma. (Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S, Izquierdo AR, Lossos IS, Reeder C, Sher T, Chen R, Schwarz SE, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM) Blood 2020 Nov 19;136(21):2401-2409 PMID: 32730586 PMCID: PMC7685206 SCOPUS ID: 2-s2.0-85094889706 07/31/2020       145 Citations
  • Use of GMI-1271, an E-selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis. (Devata S, Angelini DE, Blackburn S, Hawley A, Myers DD, Schaefer JK, Hemmer M, Magnani JL, Thackray HM, Wakefield TW, Sood SL) Res Pract Thromb Haemost 2020 Feb;4(2):193-204 PMID: 32110749 PMCID: PMC7040550 SCOPUS ID: 2-s2.0-85092793937 02/29/2020       23 Citations
  • Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma. (Reid JH, Marini BL, Nachar VR, Brown AM, Devata S, Perissinotti AJ) Crit Rev Oncol Hematol 2020 Apr;148:102897 PMID: 32109715 SCOPUS ID: 2-s2.0-85079900400 02/29/2020       4 Citations
  • Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas. (Weis TM, Marini BL, Nachar VR, Brown AM, Phillips TJ, Brown J, Wilcox RA, Kaminski MS, Devata S, Perissinotti AJ) Leuk Lymphoma 2020 May;61(5):1126-1132 PMID: 31876206 SCOPUS ID: 2-s2.0-85077371338 12/27/2019       7 Citations
  • Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy. (Girard J, Reneau J, Devata S, Wilcox RA, Kaminski MS, Mercer J, Carty S, Phillips TJ) Onco Targets Ther 2019;12:8003-8014 PMID: 31686856 PMCID: PMC6777435 SCOPUS ID: 2-s2.0-85073456878 11/07/2019       9 Citations
  • Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial. (Ahmed A, Merrill SA, Alsawah F, Bockenstedt P, Campagnaro E, Devata S, Gitlin SD, Kaminski M, Cusick A, Phillips T, Sood S, Talpaz M, Quiery A, Boonstra PS, Wilcox RA) Lancet Haematol 2019 Dec;6(12):e630-e637 PMID: 31537486 PMCID: PMC8054981 SCOPUS ID: 2-s2.0-85075336167 09/21/2019       252 Citations
  • Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. (Geer M, Roberts E, Shango M, Till BG, Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual JE, Boonstra PS, Devata S, Wilcox RA, Kaminski MS, Phillips TJ) Br J Haematol 2019 Jul;186(2):255-262 PMID: 31044423 PMCID: PMC8989046 SCOPUS ID: 2-s2.0-85065228106 05/03/2019       36 Citations
  • PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma. (Reid JH, Marini BL, Nachar VR, Devata S, Perissinotti AJ) Lancet Oncol 2019 Apr;20(4):e188 PMID: 30942175 SCOPUS ID: 2-s2.0-85063646795 04/04/2019       2 Citations
  • Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas. (Murga-Zamalloa C, Polk A, Hanel W, Chowdhury P, Brown N, Hristov AC, Bailey NG, Wang T, Phillips T, Devata S, Poonnen P, Gomez-Gelvez J, Inamdar KV, Wilcox RA) Oncotarget 2017 Dec 29;8(70):114474-114480 PMID: 29383095 PMCID: PMC5777707 SCOPUS ID: 2-s2.0-85039744412 02/01/2018       18 Citations
  • Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL). (Zhang JY, Briski R, Devata S, Kaminski MS, Phillips TJ, Mayer TL, Bailey NG, Wilcox RA) Am J Hematol 2018 Mar;93(3):394-400 PMID: 29194714 PMCID: PMC5803354 SCOPUS ID: 2-s2.0-85038114740 12/02/2017       29 Citations
  • A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. (Boonstra PS, Polk A, Brown N, Hristov AC, Bailey NG, Kaminski MS, Phillips T, Devata S, Mayer T, Wilcox RA) Am J Hematol 2017 Dec;92(12):1287-1294 PMID: 28842936 PMCID: PMC6116510 SCOPUS ID: 2-s2.0-85030175023 08/27/2017       28 Citations
  • Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders. (Phillips T, Devata S, Wilcox RA) J Immunother Cancer 2016;4:95 PMID: 28031823 PMCID: PMC5170899 SCOPUS ID: 2-s2.0-85006830422 12/30/2016       17 Citations
  • Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center. (Grivas PD, Devata S, Khoriaty R, Boonstra PS, Ruch J, McDonnell K, Hernandez-Aya L, Wilfong J, Smerage J, Ison MG, Eisenberg JNS, Silveira M, Cooney KA, Worden FP) J Cancer Educ 2017 Dec;32(4):871-877 PMID: 27055536 SCOPUS ID: 2-s2.0-84964018573 04/09/2016       8 Citations
  • Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. (Devata S, Wilcox RA) Am J Clin Dermatol 2016 Jun;17(3):225-37 PMID: 26923912 SCOPUS ID: 2-s2.0-84969824495 03/01/2016       32 Citations
  • Desmoid tumors: a comprehensive review of the evolving biology, unpredictable behavior, and myriad of management options. (Devata S, Chugh R) Hematol Oncol Clin North Am 2013 Oct;27(5):989-1005 PMID: 24093172 SCOPUS ID: 2-s2.0-84884974707 10/08/2013       42 Citations
  • Neoadjuvant chemotherapy with capecitabine and temozolomide for unresectable pancreatic neuroendocrine tumor. (Devata S, Kim EJ) Case Rep Oncol 2012 Sep;5(3):622-6 PMID: 23275776 PMCID: PMC3531952 SCOPUS ID: 2-s2.0-84873126447 01/01/2013       22 Citations
  • Detection of amyloid in abdominal fat pad aspirates in early amyloidosis: Role of electron microscopy and Congo red stained cell block sections. (Devata S, Hari P, Markelova N, Li R, Komorowski R, Shidham VB) Cytojournal 2011;8:11 PMID: 21760829 PMCID: PMC3132327 07/16/2011    
  • Performing and processing FNA of anterior fat pad for amyloid. (Shidham VB, Hunt B, Jardeh SS, Barboi AC, Devata S, Hari P) J Vis Exp 2010 Oct 30(44) PMID: 21085098 PMCID: PMC3185617 SCOPUS ID: 2-s2.0-80355133732 11/19/2010       22 Citations
  • Carboplatin and docetaxel-induced acute pancreatitis: brief report. (Singh V, Devata S, Cheng YC) Int J Clin Oncol 2010 Dec;15(6):642-4 PMID: 20602134 SCOPUS ID: 2-s2.0-78651098095 07/06/2010       13 Citations
  • Increased interleukin-6 production by cerebral cortical tissue of adult versus young mice. (Prechel MM, Halbur L, Devata S, Vaidya AM, Young MR) Mech Ageing Dev 1996 Dec 20;92(2-3):185-94 PMID: 9080398 SCOPUS ID: 2-s2.0-0030595982 12/20/1996       26 Citations
    • Last update: 03/11/2026